Health

An experimental Ebola vaccine is now being tested in people, according to scientists who say the drug has shown promising results when it was tested on monkeys. The small clinical trial is using healthy human volunteers in the U.S.

The Ebola vaccine is the subject of a study published Sunday in the journal Nature Medicine. Researchers say the vaccine treatment includes a booster shot to help the immune system fight off the virus for months after it's first administered.

Americans crave information about diets, even as our national weight keeps rising. New studies are highlighting that there is still a lot that we don't know.

Tobacco and e-cigarettes will soon be banned from many Kentucky state properties under the executive cabinet. The new policy announced by Governor Beshear  Thursday covers  state buildings, vehicles and other designated locations.

The announcement adds onto previous legislation aimed solely at cigarettes. Beshear said his executive order aims to combat Kentucky’s number one ranking in cancer and smoking deaths.

“You know, this year is the 50th anniversary of the first U.S. Surgeon General’s report alerting Americans to the deadly consequences of smoking. That’s five decades. Five decades of warnings," Beshear said.

"But warnings by themselves, as we know, are not enough.”

Many Kentuckians who lack health insurance can receive free colon cancer screenings through their local health department. The program is jointly funded through the state and private donations, and targets Kentucky residents who meet certain age and income guidelines.

Madeline Abramson, wife of Lieutenant Governor Jerry Abramson, is speaking out on behalf of colon cancer awareness in Kentucky. Mrs. Abramson is honorary chair of the Kentucky Cancer Program’s “Dress in Blue Day”, a program aimed at educating the public about colon cancer.

She says the second leading cause of cancer deaths in the nation can often be detected and treated through screenings.

“It’s unusual to have a screening test where the cancer or pre-cancerous node can be taken care of at that time," Abramson told WKU Public Radio.

Abramson says some people are embarrassed to talk about the disease in the same way many refused to openly discuss breast cancer decades ago.

Kentucky Researcher Creates Nasal Spray that Could Lower Number of Overdose Deaths

Aug 7, 2014

A nasal spray developed a Kentucky researcher is designed to reduce the number of heroin related overdoses. The invention by University of Kentucky pharmacy professor Daniel Wermeling has been fast-tracked by the Food and Drug Administration and is in its final round of clinical trials.

Wermeling’s goal was to create an easier way to administer the drug Naloxone, which can reverse potentially fatal heroin overdoses. He has been working on the nasal spray since 2009, with support from a $3 million grant from the National Institutes of Health, with additional funding from the Kentucky Science and Technology Corp.

If the F.D.A gives final approval to the product, it could be available by prescription as early as next year.

Wermeling believes the nasal spray will be a much easier way to treat patients, as opposed to injecting them with the drug.

The percentage of people without health insurance in Kentucky has dropped at the second biggest rate in the nation.

According to a Gallup poll released this week, the  number of uninsured dropped from over 20 percent in 2013 to about 12 percent as of July 2014, reflecting an eight-and-a-half percent decline since the federal Affordable Care Act took effect. The only other state to experience a sharper decline was Arkansas, whose uninsured rate dropped about 10 percent.

The states rounding out the top five after Kentucky are Delaware, Washington and Colorado.

Gov. Steve Beshear touted the news in a press release, attributing the new data to the state’s implementation of the ACA via kynect, the state’s health insurance exchange.

The poll also reported that the rate of uninsured in 21 states like Kentucky that expanded Medicaid coverage under the ACA and set up their own  exchanges declined “more significantly” than those states that did not.

As of July, over 520,000 Kentuckians have enrolled in health care through the state exchange, with three-quarters of the newly insured enrolled in Medicaid.

Kentucky will receive over $1 million from the Centers for Disease Control and Prevention to combat prescription drug abuse.

The money will be spread out over three years and used to enhance the state’s prescription drug monitoring program. Kentucky has the third highest rate of drug overdose deaths in the nation, and has recently seen a surge in the number of deaths related to heroin.

The funding was announced Tuesday in Paintsville by CDC Director Thomas Frieden. He was joined by Rep. Hal Rogers, a Somerset Republic who represents the state’s 5th District. During his announcement, Frieden lauded efforts made by the commonwealth to crack down on the illegal prescription drug trade.

In recent years, state lawmakers have passed legislation cracking down on pill mills, which are clinics that abuse their prescription-writing authority for people seeking pain medication for recreational use. Kentucky also requires controlled substance prescribers to use KASPER, the state’s prescription monitoring program.

The CDC says the number of KASPER reports has more than tripled since those laws went into effect, and there has been a nine-percent decline in the amount of controlled substance dispensing in the commonwealth.

While VA hospitals are dealing with long wait times, Fort Campbell’s health system has excess capacity. Blanchfield Army Community Hospital has reopened its facilities to a limited number of retirees for the first time in a decade. Enrollment was cut off to veterans in 2004 because so many doctors and nurses were deployed to the Middle East.

This week, NPR Ed is focusing on questions about why people play and how play relates to learning.

When it comes to brain development, time in the classroom may be less important than time on the playground.

Kentucky BioProcessing

An experimental drug used to treat two Americans infected with the Ebola virus was created in Owensboro.

Kent Brantly and Nancy Writebol are reportedly showing significant improvement after being treated at an Atlanta hospital with a drug called ZMapp.

Compounds used in the drug are grown in genetically modified tobacco plants in an effort overseen by the Owensboro-based Kentucky BioProcessing. The Herald-Leader reports that KBP received a federal contract in 2007 to work on a drug that could treat those exposed to the Ebola virus.

An Ebola outbreak in west Africa has claimed nearly 900 lives, with many more victims infected. Brantly and Writebol, who were giving medical treatment to Ebola victims when they fell ill, are the first known humans to receive Z-Mapp.

A spokesman for the company that runs the Owensboro operation says production of the drug was already being ramped up for approval testing later this year, and that schedule may accelerate given the magnitude of the current Ebola outbreak.

KBP is also involved with the Owensboro Cancer Research program, which this week was given a federal grant to further its research into a possible HIV vaccine using tobacco plants.

Pages